Association between TCF7L2 Genotype and Glycemic Control in Diabetic Patients Treated with Gliclazide

Table 2

Baseline characteristics across TCF7L2 rs7903146 genotypes in the entire group.

Entire group (𝑛=101)	CC (𝑛=51)	CT (𝑛=41)	TT (𝑛=9)	𝑃
Sex (males/females)	28/23	18/23	4/5	0.535
Age (years)	61.7±1.4	62.0±1.6	62.9±3.8	0.945
Diabetes duration (years)	2.6±0.4	2.0±0.2	2.0±0.8	0.444
Baseline BMI (kg/m^2)	31.0±0.7	30.1±0.4	30.7±0.9	0.601
Baseline HbA1c (%)	8.06±0.14	8.01±0.13	8.06±0.27	0.954
SU dose (% max dose)	43.6±2.3	50.6±3.3	49.1±5.5	0.195

𝑃 values for 𝜒²-test (gender) and for ANOVA.